Antinocieptive and anti-inflammatory effects of Toddalia asiatica (L) Lam. (Rutaceae) root extract in Swiss albino mice

被引:17
作者
Kariuki, Hellen Nyambura [1 ]
Kanui, Titus Ikusya [2 ]
Yenesew, Abiy [1 ]
Patel, Nilesh [1 ]
Mbugua, Paul Mungai [3 ]
机构
[1] Univ Nairobi, POB 30197, Nairobi 00100, Kenya
[2] South Eastern Univ Coll, Sch Agr & Vet Sci, Kitui 90200, Kenya
[3] Presbyterian Univ East Africa, Kikuyu 00902, Kenya
来源
PAN AFRICAN MEDICAL JOURNAL | 2013年 / 14卷
关键词
Toddalia asiatica; root extract; formalin test; carrageenin test; Antinociceptive; Anti-inflammatory; mice;
D O I
10.11604/pamj.2013.14.133.2130
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Toddalia asiatica is a commonly used medicinal plant in East Africa for the management of pain and inflammatory conditions. The present study investigated the antinociceptive and the anti-inflammatory effects of T. asiatica in Swiss albino mice. Methods: The antinociceptive and the anti-inflammatory effects of T. asiatica were investigated using formalin-induced pain test and the carrageenin-induced oedema paw. The extract solvent (vehicle), aspirin and indomethacin were employed as negative and positive controls respectively. Eight mice were used in each experiment. Results: In the early phase of the formalin test, the 100mg/kg dose showed no significant antinociceptive activity while the 200mg/kg showed significant (p < 0.01) antinociceptive activity. The 100 mg/kg dose showed highly significant antinociceptive activity (p < 0.001) in the late phase of the formalin test while the 200mg/kg dose showed no significant antinociceptive activity. A reduction in carragenin induced acute inflammation paw oedema was significant (p < 0.01) following administration of 100mg/kg dose but not with the 200mg/kg dose. Conclusion: The present study therefore lends support to the anecdotal evidence for use of T. asiatica in the management of painful and inflammatory conditions.
引用
收藏
页数:5
相关论文
共 20 条
  • [1] [Anonymous], GUID US LAB AN DHHS, V85-23
  • [2] Balasubramaniam LA, 2011, GLOBAL J PHARM, V5, P67
  • [3] Chronic pain in Australia: a prevalence study
    Blyth, FM
    March, LM
    Brnabic, AJM
    Jorm, LR
    Williamson, M
    Cousins, MJ
    [J]. PAIN, 2001, 89 (2-3) : 127 - 134
  • [4] BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P896
  • [5] CODERRE TJ, 1992, J NEUROSCI, V12, P3665
  • [6] Analgesic-like Activity of Essential Oils Constituents
    de Sousa, Damiao Pergentino
    [J]. MOLECULES, 2011, 16 (03): : 2233 - 2252
  • [7] Hao XY, 2004, CHIN J INTEGR MED, V2, P450, DOI DOI 10.3736/JCIM20040615
  • [8] Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro
    Hollander, Camilla
    Nystrom, Max
    Janciauskiene, Sabina
    Westin, Ulla
    [J]. CANCER CELL INTERNATIONAL, 2003, 3 (1)
  • [9] Kanui T.I., 2006, P ANN DAAD SCH C KEN, P26
  • [10] Kariuki HN, 2012, PHYTOPHARMACOLOGY, V3, P122